Análisis de factores asociados a las alertas de desabastecimiento de medicamentos presentadas en Colombia entre 2012 y 2018
| dc.contributor.advisor | Aponte González, Johanna Andrea | spa |
| dc.contributor.advisor | Vaca González, Claudia Patricia | spa |
| dc.contributor.author | López López, Janeth Stefany | spa |
| dc.contributor.researchgroup | RAM (Red para el Uso Adecuado de Medicamentos) | spa |
| dc.date.accessioned | 2021-03-02T14:53:46Z | spa |
| dc.date.available | 2021-03-02T14:53:46Z | spa |
| dc.date.issued | 2021-02-16 | spa |
| dc.description.abstract | The drug shortage has been characterized as a problem that affects public health and has been increasing around the world. The objective of this study is to analyze the behavior of factors associated with drug shortage presented in Colombia between 2012 and 2018. The research was carried out in four stages: 1) selection of the factors to be analyzed, identified through a systematic review of the literature, 2) identification of the drugs considered to be stocked in Colombia between the years 2012-2018, 3) description of the factors selected for stock-out drugs and 4) adaptation of a proposed statistical model to evaluate the relationship of the variables of interest with the shortage of medicines in Colombia. In accordance with the foregoing, multiple causes were identified that have been described in the literature and that are associated with problems in manufacturing, distribution, service provision, product or market characteristics, and regulatory requirements or measures. In Colombia, there were a total of 73 drugs shortages presented between 2012-2018, with the majority therapeutic groups being antineoplastic and anti-infective drugs. It was observed that the cases of shortages present high market concentrations (IHH> 2,500). Likewise, a low percentage of imports, increases in the Fisher index and injectable and ophthalmic pharmaceutical forms are related to shortage moments. Price control did not show the relationship with drug shortage. Some factors associated with shortages were identified to provide information for decision-making in public policy and that would allow the construction of measures to address shortages. | spa |
| dc.description.abstract | El desabastecimiento de medicamentos se ha caracterizado por ser un problema que afecta la salud pública y ha ido en aumento alrededor del mundo. El objetivo de este estudio es analizar el comportamiento de factores asociados a las alertas de desabastecimiento de medicamentos presentados en Colombia entre 2012 y 2018. La investigación se realizó en cuatro etapas: 1) selección de los factores a analizar, identificados mediante una revisión sistemática de la literatura, 2) identificación de los medicamentos considerados desabastecidos en Colombia entre los años 2012-2018, 3) descripción de los factores seleccionados para los medicamentos desabastecidos y 4) adaptación de un modelo estadístico propuesto para evaluar la relación de las variables de interés con el desabastecimiento de medicamentos en Colombia. Conforme a lo anterior, se identificaron múltiples causas que se han descrito en la literatura y que están asociadas a problemas de manufactura, distribución, prestación del servicio, características del producto o del mercado y, los requisitos o medidas regulatorias. En Colombia, los medicamentos desabastecidos presentados entre 2012-2018 fueron en total 73, siendo los grupos terapéuticos mayoritarios los antineoplásicos y antiinfecciosos. Se observó que los casos de desabastecimiento presentan altas concentraciones de mercado (IHH >2.500). Así mismo, que un bajo porcentaje de importación, aumentos en el índice Fisher y que las formas farmacéuticas inyectables y oftálmicas se relacionan con los momentos de desabastecimiento, a diferencia del control de precios que no mostró dicha relación. Se identificaron algunos factores asociados a las situaciones de desabastecimiento que brindan información para la toma de decisiones en política pública y que permitirían la construcción de medidas para hacer frente al desabastecimiento. | spa |
| dc.description.additional | Línea de Investigación: Farmacoepidemiología | spa |
| dc.description.degreelevel | Maestría | spa |
| dc.format.extent | 90 páginas | spa |
| dc.format.mimetype | application/pdf | spa |
| dc.identifier.uri | https://repositorio.unal.edu.co/handle/unal/79335 | |
| dc.language.iso | spa | spa |
| dc.publisher.branch | Universidad Nacional de Colombia - Sede Bogotá | spa |
| dc.publisher.department | Departamento de Farmacia | spa |
| dc.publisher.program | Bogotá - Ciencias - Maestría en Ciencias - Farmacología | spa |
| dc.relation.references | Invima. Instituto Nacional de Vigilancia de Medicamentos y Alimentos. Desabastecimiento de medicamentos [Internet]. 2018 [cited 2019 Mar 4]. Available from: https://www.invima.gov.co/desabastecimiento-de-medicamentos#estado-de-abastecimiento-de-medicamentos | spa |
| dc.relation.references | Schwartzberg E, Ainbinder D, Vishkauzan A, Gamzu R. Drug shortages in Israel: regulatory perspectives, challenges and solutions. Isr J Health Policy Res [Internet]. 2017 [cited 2019 Feb 26];6(17):1–8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376685/pdf/13584_2017_Article_140.pdf | spa |
| dc.relation.references | Nonzee NJ, Luu TH. The Drug Shortage Crisis in the United States: Impact on Cancer Pharmaceutical Safety. Cancer Policy Pharm Safety, Cancer Treat Res [Internet]. 2019;171:75–92. Available from: http://link.springer.com/10.1007/978-3-319-43896-2 | spa |
| dc.relation.references | Bogaert P, Bochenek T, Prokop A, Pilc A. A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union’s Perspectives. PLoS One [Internet]. 2015 [cited 2019 Mar 2];10(5):1–20. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420462/pdf/pone.0125691.pdf | spa |
| dc.relation.references | Heiskanen K, Ahonen R, Kanerva R, Karttunen P, Timonen J. The reasons behind medicine shortages from the perspective of pharmaceutical companies and pharmaceutical wholesalers in Finland. PLoS One [Internet]. 2017 [cited 2019 Mar 2];12(6). Available from: https://doi.org/10.1371/journal.pone.0179479 | spa |
| dc.relation.references | Yang C, Wu L, Cai W, Zhu W, Shen Q, Li Z, et al. Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study. PLoS One [Internet]. 2016 [cited 2019 Mar 2];11(10):1–16. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079602/pdf/pone.0165183.pdf | spa |
| dc.relation.references | Alruthia YS, Alwhaibi M, Alotaibi MF, Asiri SA, Alghamdi BM, Almuaythir GS, et al. Drug shortages in Saudi Arabia: Root causes and recommendations. Saudi Pharm J [Internet]. 2018 [cited 2019 Feb 26];26:947–51. Available from: https://doi.org/10.1016/j.jsps.2018.05.002 | spa |
| dc.relation.references | Instituto Nacional de Vigilancia de Medicamentos y Alimentos - Invima. Informe de gestión del desabastecimiento de medicamentos en Colombia 2013-2018 [Internet]. Bogotá; 2018 [cited 2019 Mar 4]. Available from: https://www.invima.gov.co/desabastecimiento- | spa |
| dc.relation.references | Dranitsaris G, Jacobs I, Kirchhoff C, Popovian R, Shane LG. Drug tendering: drug supply and shortage implications for the uptake of biosimilars. Clin Outcomes Res [Internet]. 2017 [cited 2019 Feb 20];9:573–84. Available from: http://dx.doi.org/10.2147/CEOR.S140063 | spa |
| dc.relation.references | Rinaldi F, de Denus S, Nguyen A, Nattel S, Bussières JF. Drug Shortages: Patients and Health Care Providers Are All Drawing the Short Straw. Can J Cardiol [Internet]. 2017;33(2):283–6. Available from: http://dx.doi.org/10.1016/j.cjca.2016.08.010 | spa |
| dc.relation.references | Frosch ZAK, Cronin AM, Gagne JJ, Teschke MP, Gray SW, Abel GA. Cancer drug shortages: Awareness and perspectives from a representative sample of the US population. Cancer. 2018;124(10):2205–11. | spa |
| dc.relation.references | The Sixty-ninth World Health Assembly. Addressing the global shortage of medicines and vaccines [Internet]. 2016 [cited 2019 Mar 30]. Available from: http://apps.who.int/medicinedocs/documents/s22423en/s22423en.pdf | spa |
| dc.relation.references | Pauwels K, Huys I, Casteels M, Simoens S. Drug shortages in European countries: a trade-off between market attractiveness and cost containment? BMC Health Serv Res [Internet]. 2014 [cited 2019 Mar 28];14(438):1–9. Available from: http://www.biomedcentral.com/1472-6963/14/438 | spa |
| dc.relation.references | Mazer-Amirshahi M, Fox ER, Zocchi MS, Pines JM, Van Den Anker JN. Longitudinal trends in U.S. shortages of sterile solutions, 2001–17. Am J Heal Pharm. 2018;75(23):1903–8. | spa |
| dc.relation.references | Borges Rosa M, Max Moreira Reis A, Perini E. Drug shortage: a public health problem. Perspectivas [Internet]. 2016 [cited 2019 Mar 2];32(10). Available from: http://dx.doi.org/10.1590/0102-311X00086916 | spa |
| dc.relation.references | Videau M, Lebel D, Bussières JF. Drug shortages in Canada: Data for 2016–2017 and perspectives on the problem. Ann Pharm Fr [Internet]. 2019; Available from: https://doi.org/10.1016/j.pharma.2018.11.007 | spa |
| dc.relation.references | Kaakeh R, Sweet B V., Reilly C, Bush C, DeLoach S, Higgins B, et al. Impact of drug shortages on U.S. health systems. Am J Heal Pharm. 2011;68(19):1811–9. | spa |
| dc.relation.references | Shaban H, Maurer C, Willborn RJ. Impact of Drug Shortages on Patient Safety and Pharmacy Operation Costs. fedprac [Internet]. 2018 [cited 2019 Mar 2];24–31. Available from: www.fedprac.com | spa |
| dc.relation.references | Detsis M, Mylonakis E, Machan JT, Grigoras CA, Alevizakos M. The Impact of Shortages on Medication Prices: Implications for Shortage Prevention. Drugs. 2016;76(16):1551–8. | spa |
| dc.relation.references | Rinaldi F, de Denus S, Nguyen A, Nattel S, Bussières J-F. Drug Shortages: Patients and Health Care Providers Are All Drawing the Short Straw. Can J Cardiol [Internet]. 2017 Feb [cited 2019 Feb 20];33(2):283–6. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0828282X1630842X | spa |
| dc.relation.references | van den Anker JN, Fox E, Ziesenitz VC, Mazer-Amirshahi M, Zocchi M, Samiee-Zafarghandy S. Prescription Drug Shortages: Impact on Neonatal Intensive Care. Neonatology. 2019;115:108–15. | spa |
| dc.relation.references | Claus B, Bauters T, Laureys G. Drug shortages in a pediatric stem cell transplantation ward: Challenges and implications. A 5-year bilan. J Oncol Pharm Pract. 2018; | spa |
| dc.relation.references | Bogyi M, Krivec U, Salo E, Blázquez D, Ruga E, Soriano-Arandes A, et al. The impact of Bacille Calmette-Guérin shortage on immunisation practice and policies in Europe – A Paediatric Tuberculosis Network European Trials Group (ptbnet) survey. Tuberculosis. 2016;101:125–9. | spa |
| dc.relation.references | McGrath S, Perera M, Manning T, Bolton D, Roberts M, Christidis D, et al. The impact of the global bacille Calmette-Guérin shortage on treatment patterns: population-based data. BJU Int. 2017;121(2):169–72. | spa |
| dc.relation.references | Barber KE, Bell AM, Travis King S, Parham JJ, Stover KR. Impact of piperacillin-tazobactam shortage on meropenem use: implications for antimicrobial stewardship programs. Braz J Infect Dis [Internet]. 2016 [cited 2019 Mar 2];20(6):631–43. Available from: http://dx.doi.org/10.1016/j.bjid.2016.08.001 | spa |
| dc.relation.references | Vail E, Gershengorn HB, Hua M, Walkey AJ, Rubenfeld G, Wunsch H. Association between US norepinephrine shortage and mortality among patients with septic shock. JAMA - J Am Med Assoc. 2017;317(14):1433–42. | spa |
| dc.relation.references | Schjøtt J, Torgauten HM, Bjånes TK. Shortage of Digitoxin and Switching to Digoxin in Norway: A Retrospective Study of Blood Samples Submitted to a Clinical Pharmacology Laboratory. Basic Clin Pharmacol Toxicol. 2017;121(1):74–7. | spa |
| dc.relation.references | Tan VS, Nash DM, McArthur E, Jain AK, Garg AX, Juurlink DN, et al. Impact of Injectable Furosemide Hospital Shortage on Congestive Heart Failure Outcomes: A Time Series Analysis. Can J Cardiol [Internet]. 2017;33(11):1498–504. Available from: http://dx.doi.org/10.1016/j.cjca.2017.09.003 | spa |
| dc.relation.references | McLaughlin Sarah H Sutton Ashley O Jensen John S Esterly MM. Use of High-Dose Oral Valacyclovir During an Intravenous Acyclovir Shortage: A Retrospective Analysis of Tolerability and Drug Shortage Management. Infect Dis Ther [Internet]. 2017 [cited 2019 Mar 2];6:259–64. Available from: http://www.medengine.com/Redeem/ | spa |
| dc.relation.references | Malone C, Acheson JR, Mccomiskey MH. Uterotonics for Non-emergent Caesarean Section: Protocol Change During UK-Licensed Drug Shortage [Internet]. Vol. 85, Ulster Med J. 2016 [cited 2019 Mar 2]. Available from: http://www.ums.ac.uk | spa |
| dc.relation.references | Alpert A, Jacobson M. Impact of Oncology Drug Shortages on Chemotherapy Treatment. Clin Pharmacol Ther [Internet]. 2019; Available from: http://www.ncbi.nlm.nih.gov/pubmed/30739322%0Ahttp://doi.wiley.com/10.1002/cpt.1390 | spa |
| dc.relation.references | Traynor K. Workshop examines drug shortage solutions during disasters [Internet]. 2018 [cited 2019 Mar 2]. Available from: https://academic.oup.com/ajhp/article-abstract/75/21/1679/5160005 | spa |
| dc.relation.references | Kweder SL, Dill S. Drug shortages: The cycle of quantity and quality. Clin Pharmacol Ther. 2013;93(3):245–51. | spa |
| dc.relation.references | Instituto Nacional de Vigilancia de Medicamentos y Alimentos - Invima. Circular Externa 1000-040-18. 2018. | spa |
| dc.relation.references | Beck JC, Chen B, Gordon BG. Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists Retrospective Study. World J Clin Oncol. 2017;8(4):336–42. | spa |
| dc.relation.references | Russell H V., Bernhardt MB, Berg S. Using decision modeling to guide drug allocation during a shortage. Pediatr Blood Cancer. 2017;64(7). | spa |
| dc.relation.references | Dave C V., Pawar A, Fox ER, Brill G, Kesselheim AS. Predictors of Drug Shortages and Association with Generic Drug Prices: A Retrospective Cohort Study. Value Heal [Internet]. 2018;21(11):1286–90. Available from: http://dx.doi.org/10.1016/j.jval.2018.04.1826 | spa |
| dc.relation.references | De Weerdt E, Simoens S, Casteels M, Huys I. Clinical, Economic and Policy Implications of Drug Shortages in the European Union. Appl Health Econ Health Policy. 2017;15(4):441–5. | spa |
| dc.relation.references | ISAGS-UNASUR. Situación de medicamentos esenciales con riesgo de desabastecimiento con énfasis en los países suramericanos [Internet]. 2017 [cited 2019 Mar 4]. Available from: http://isags-unasur.org/wp-content/uploads/2018/06/desabastecimiento-final-esp.pdf | spa |
| dc.relation.references | Díaz JC. La teoría de los índices de precios. Cuad Estud Empres. 1997;(7):71–88. | spa |
| dc.relation.references | Carmona F. Números índice. Universidad de Barcelona; 2001. | spa |
| dc.relation.references | Rueda JG, Zamudio Gómez N. Medidas de Concentración y Competencia. | spa |
| dc.relation.references | González-Garay A. Generalidades de los estudios de casos y controles. Acta Pediatr Mex [Internet]. 2018 [cited 2020 Feb 13];39(1):72–80. Available from: www.actapediatrica.org.mx | spa |
| dc.relation.references | Wachoider S, Silverman DT, Mclaughlin JK, Mandel JS. Selection of Controls in Case-Control Studies III. Design Options. Vol. 135, American JounaJ of Epidemiology. 1992. | spa |
| dc.relation.references | Atif M, Malik I, Mushtaq I, Asghar S. Medicines shortages in Pakistan: a qualitative study to explore current situation, reasons and possible solutions to overcome the barriers. BMJ Open [Internet]. 2019 Sep 4 [cited 2019 Sep 25];9(9):e027028. Available from: http://www.ncbi.nlm.nih.gov/pubmed/31488466 | spa |
| dc.relation.references | Walker J, Chaar BB, Vera N, Pillai AS, Lim JS, Bero L, et al. Medicine shortages in Fiji: A qualitative exploration of stakeholders’ views. PLoS One [Internet]. 2017 [cited 2019 Sep 26];12(6):e0178429. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28582409 | spa |
| dc.relation.references | Tan YX, Moles RJ, Chaar BB. Medicine shortages in Australia: causes, impact and management strategies in the community setting. Int J Clin Pharm [Internet]. 2016 Oct 6 [cited 2019 Sep 26];38(5):1133–41. Available from: http://link.springer.com/10.1007/s11096-016-0342-1 | spa |
| dc.relation.references | Awad H, Al-Zu’bi ZMF, Abdallah AB. A Quantitative Analysis of the Causes of Drug Shortages in Jordan: A Supply Chain Perspective. Int Bus Res [Internet]. 2016 Mar 29 [cited 2019 Sep 25];9(6):53. Available from: http://www.ccsenet.org/journal/index.php/ibr/article/view/57405 | spa |
| dc.relation.references | Pauwels K, Simoens S, Casteels M, Huys I. Insights into European Drug Shortages: A Survey of Hospital Pharmacists. Conly J, editor. PLoS One [Internet]. 2015 Mar 16 [cited 2019 Sep 26];10(3):e0119322. Available from: https://dx.plos.org/10.1371/journal.pone.0119322 | spa |
| dc.relation.references | Al-Ruthia YS, Mansy W, Barasin M, Ghawaa YM, AlSultan M, Alsenaidy MA, et al. Shortage of psychotropic medications in community pharmacies in Saudi Arabia: Causes and solutions. Saudi Pharm J SPJ Off Publ Saudi Pharm Soc [Internet]. 2017 Jul [cited 2019 Sep 26];25(5):744–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28725147 | spa |
| dc.relation.references | Stomberg C. Drug shortages, pricing, and regulatory activity [Internet]. 2016 [cited 2019 Sep 26]. Available from: https://www.nber.org/papers/w22912.pdf | spa |
| dc.relation.references | Heiskanen K, Ahonen R, Karttunen P, Kanerva R, Timonen J. Medicine shortages – A study of community pharmacies in Finland. Health Policy (New York) [Internet]. 2015 Feb 1 [cited 2019 Sep 26];119(2):232–8. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0168851014002851?via%3Dihub | spa |
| dc.relation.references | Costelloe EM, Guinane M, Nugent F, Halley O, Parsons C. An audit of drug shortages in a community pharmacy practice. Irish J Med Sci (1971 -) [Internet]. 2015 Jun 25 [cited 2019 Sep 26];184(2):435–40. Available from: http://link.springer.com/10.1007/s11845-014-1139-7 | spa |
| dc.relation.references | Mori J, Hasui K, Tanimoto T, Matsumura T, Kami M. Drug Shortages After the Eastern Japan Earthquake: Experiences in a Tertiary Referral Center. Drug Inf J [Internet]. 2012 Sep 29 [cited 2019 Sep 26];46(5):607–10. Available from: http://journals.sagepub.com/doi/10.1177/0092861512448569 | spa |
| dc.relation.references | Ziesenitz VC, Mazer-Amirshahi M, Zocchi MS, Fox ER, May LS. U.S. vaccine and immune globulin product shortages, 2001–15. Am J Heal Pharm [Internet]. 2017 Nov 15 [cited 2019 Sep 25];74(22):1879–86. Available from: https://academic.oup.com/ajhp/article/74/22/1879/5102671 | spa |
| dc.relation.references | Mazer-Amirshahi M, Goyal M, Umar SA, Fox ER, Zocchi M, Hawley KL, et al. U.S. drug shortages for medications used in adult critical care (2001–2016). J Crit Care [Internet]. 2017 Oct 1 [cited 2019 Sep 26];41:283–8. Available from: https://www.sciencedirect.com/science/article/abs/pii/S0883944117302344?via%3Dihub | spa |
| dc.relation.references | GAO. Drug shortages: Certain Factors Are Strongly Associated with This Persistent Public Health Challenge [Internet]. 2016 [cited 2019 Sep 25]. Available from: https://www.gao.gov/assets/680/678281.pdf | spa |
| dc.relation.references | Parsons HM, Schmidt S, Karnad AB, Liang Y, Pugh MJ, Fox ER. Association Between the Number of Suppliers for Critical Antineoplastics and Drug Shortages: Implications for Future Drug Shortages and Treatment. J Oncol Pract [Internet]. 2016 Mar [cited 2019 Sep 26];12(3):e289-98, 249–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26837565 | spa |
| dc.relation.references | Haninger K, Jessup A, Koehler K. Economic analysis of the causes of drug shortages [Internet]. 2011 [cited 2019 Sep 25]. Available from: https://aspe.hhs.gov/system/files/pdf/108986/ib.pdf | spa |
| dc.relation.references | Fox ER, Tyler LS. Managing drug shortages: Seven years’ experience at one health system. Am J Heal Pharm [Internet]. 2003 Feb 1 [cited 2019 Sep 25];60(3):245–53. Available from: https://academic.oup.com/ajhp/article/60/3/245/5143030 | spa |
| dc.relation.references | Fox ER, Associate Professor A, McLaughlin MM, Professor A. ASHP guidelines on managing drug product shortages. Am J Heal Pharm [Internet]. 2018 [cited 2019 Mar 2];75(21):1742–50. Available from: https://academic.oup.com/ajhp/article-abstract/75/21/1742/5160014 | spa |
| dc.relation.references | Benhabib A, Ioughlissen S, Ratignier-Carbonneil C, Maison P. The French reporting system for drug shortages: description and trends from 2012 to 2018: an observational retrospective study. BMJ Open. 2020;10:34033. | spa |
| dc.relation.references | Aguilar A, Linares Y. EVALUACIÓN DE LAS CONSECUENCIAS DEL DESABASTECIMIENTO DE MEDICAMENTOS ONCOLÓGICOS EN LOS SERVICIOS FARMACÉUTICOS DE BOGOTÁ. Universidad de Ciencias Aplicadas y Ambientales; 2019. | spa |
| dc.relation.references | Cuenta de alto costo. Situación del Cáncer en la población adulta atendida en el SGSSS de Colombia. 2019 | spa |
| dc.relation.references | Vaca CP. La paradoja global de los medicamentos para el cáncer [Internet]. UN Periódico -Universidad Nacional. 2012 [cited 2021 Jan 25]. Available from: https://www.minsalud.gov.co/Paginas/La-paradoja-global-de-los-medicamentos-para-el-cáncer-.aspx | spa |
| dc.relation.references | Secretaría organizada por el Programa de las Naciones Unidas para el Desarrollo. Informe del GRUPO DE ALTO NIVEL DEL SECRETARIO GENERAL DE LAS NACIONES UNIDAS SOBRE EL ACCESO A LOS MEDICAMENTOS [Internet]. 2016 [cited 2021 Feb 15]. Available from: www.phoenixdesignaid.com. | spa |
| dc.relation.references | Gonzales A. Impacto clínico y económico del desabastecimiento de medicamentos para el tratamiento de cáncer de mama en Colombia. Universidad Nacional de Colombia; 2019. | spa |
| dc.relation.references | Ministerio de Salud y Protección Social. Guía de práctica clínica (GPC) basada en la evidencia para la atención integral de la sífilis gestacional y congénita [Internet]. 2014 [cited 2021 Jan 30]. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/INEC/IETS/gpc –guia-completa-sifilis.pdf | spa |
| dc.relation.references | Organización FS por D y la, Usuarios de C y. El desabastecimiento y la escasez de medicamentos [Internet]. No es sano. 2020 [cited 2021 Jan 30]. p. 8. Available from: https://www.medicosdelmundo.org/sites/default/files/informe_desabastecimientos_nes.pdf | spa |
| dc.relation.references | Instituto Nacional de Salud. Comportamiento de sífilis gestacional y sífilis congénita, Colombia a período epidemiológico VII 2020 [Internet]. 2020 [cited 2021 Jan 30]. Available from: https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2020_Boletin_epidemiologico_semana_30.pdf | spa |
| dc.relation.references | López JJ, Garay AM. Study of the use of antibiotics in the outpatient service of a public hospital in Bogotá, D. C. Rev Colomb Ciencias Químico-Farmacéuticas. 2016;45(1):456. | spa |
| dc.relation.references | Ministerio de Salud y Protección Social. Circular 03 de 2013 [Internet]. [cited 2021 Jan 20]. Available from: https://www.minsalud.gov.co/Normatividad_Nuevo/Circular Externa Conjunta 0003 de 2013.pdf | spa |
| dc.relation.references | Jim I. La concentración de mercado en el sector farmacéutico colombiano 2002-2003 . Un análisis parcial para las enfermedades cerebrovasculares e isquemias , diabetes mellitus. Ecos Econ. 2005;21:174–202. | spa |
| dc.relation.references | Collazo Herrera MM. El poder de mercado de la industria farmacéutica. Rev Cuba Farm [Internet]. 1997 [cited 2021 Jan 21];31(2). Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75151997000200009 | spa |
| dc.relation.references | ANDI C de la industria farmacéutica-. CIFRAS SECTOR SALUD MERCADO FARMACÉUTICO. 2020. | spa |
| dc.relation.references | Ministerio de Salud y Protección Social. SISMED. | spa |
| dc.relation.references | Aizcorbe A, Nestoriak N. Price Indexes for Drugs: A Review of the Issues. 2012. | spa |
| dc.relation.references | Ministerio de Salud y Protección Social. Boletin 02 SISMED [Internet]. 2019 [cited 2021 Jan 22]. p. 19. Available from: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/VS/MET/boletin-sismed-02-2019.pdf | spa |
| dc.relation.references | Ministerio de Salud y Protección Social. Desabastecimiento - Ministerio de Salud y Protección Social [Internet]. [cited 2021 Jan 31]. Available from: https://www.minsalud.gov.co/salud/MT/Paginas/desabastecimiento.aspx | spa |
| dc.relation.references | Invima. Medicamentos Vitales No Disponibles [Internet]. Available from: https://www.invima.gov.co/medicamentos-vitales-no-disponibles | spa |
| dc.relation.references | Fox ER, Tyler LS. Potential Association between Drug Shortages and High-Cost Medications. Pharmacotherapy. 2017;37(1):36–42. | spa |
| dc.relation.references | Dave C V., Kesselheim AS, Fox ER, Qiu P, Hartzema A. High generic drug prices and market competition: A retrospective cohort study. Ann Intern Med. 2017;167(3):145–51. | spa |
| dc.rights | Derechos reservados - Universidad Nacional de Colombia | spa |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.license | Atribución-NoComercial-SinDerivadas 4.0 Internacional | spa |
| dc.rights.spa | Acceso abierto | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | spa |
| dc.subject.ddc | 610 - Medicina y salud::615 - Farmacología y terapéutica | spa |
| dc.subject.proposal | Shortage | eng |
| dc.subject.proposal | Desabastecimiento | spa |
| dc.subject.proposal | Medicamentos | spa |
| dc.subject.proposal | Drug | eng |
| dc.subject.proposal | Public health | eng |
| dc.subject.proposal | Salud pública | spa |
| dc.subject.proposal | Price index | eng |
| dc.subject.proposal | Índice de precios | spa |
| dc.subject.proposal | Importación de medicamentos | spa |
| dc.subject.proposal | Import of medicines | eng |
| dc.title | Análisis de factores asociados a las alertas de desabastecimiento de medicamentos presentadas en Colombia entre 2012 y 2018 | spa |
| dc.type | Trabajo de grado - Maestría | spa |
| dc.type.coar | http://purl.org/coar/resource_type/c_bdcc | spa |
| dc.type.coarversion | http://purl.org/coar/version/c_ab4af688f83e57aa | spa |
| dc.type.content | Text | spa |
| dc.type.driver | info:eu-repo/semantics/masterThesis | spa |
| dc.type.version | info:eu-repo/semantics/acceptedVersion | spa |
| oaire.accessrights | http://purl.org/coar/access_right/c_abf2 | spa |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- Tesis_DocumentoFinal_JanethLopez_VF.pdf
- Tamaño:
- 2.31 MB
- Formato:
- Adobe Portable Document Format
- Descripción:
- Tesis de Maestría en Ciencias - Farmacología
Bloque de licencias
1 - 1 de 1
Cargando...
- Nombre:
- license.txt
- Tamaño:
- 3.87 KB
- Formato:
- Item-specific license agreed upon to submission
- Descripción: